Multiplex PCR Primer Design for Accurate HBA12 Genotyping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional PCR-based tests struggle to accurately identify HBA12 genotypes due to frequent intergenic exchange between HBA1 and HBA2 genes, leading to false negative results in diagnosing genetic diseases like thalassemia and sickle cell anemia, particularly in populations where HBA12 is prevalent.

Innovation Solution

A multiplex PCR-based method that simultaneously detects HBA1, HBA2, and HBA12 genes using specific primers (MA1F, MA12R, MA2F, MA2R, MA12F, and MA2R) to overcome the limitations of conventional tests, allowing for accurate diagnosis and treatment of associated diseases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional PCR methods are used to detect HBA1 and HBA2 genes, then the detection process is simple, but false negative results occur in populations with HBA12 gene conversion

Engineering Contradiction:
Improvedetection accuracyVSAvoidtest complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The detection system is segmented into three distinct primer sets, each specifically designed to target one of the three alpha-globin genes (HBA1, HBA2, HBA12). This segmentation allows each primer set to independently and specifically amplify its target gene, preventing cross-reactivity and ensuring accurate detection of all three genes simultaneously, thereby resolving the false negative issue while maintaining manageable complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The multiplex PCR assay performs multiple detection functions in a single test procedure. By incorporating three different primer sets that can simultaneously amplify HBA1, HBA2, and HBA12 genes, the system achieves multi-functionality, allowing comprehensive genotyping in one reaction rather than requiring separate tests for each gene variant

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If separate PCR tests are performed for each HBA gene variant, then detection accuracy is high, but time and cost increase

Engineering Contradiction:
Improvegenotype identification accuracyVSAvoidtesting efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention merges the detection of three separate HBA gene variants (HBA1, HBA2, HBA12) into a single multiplex PCR assay. By combining multiple primer sets in one reaction mixture and performing simultaneous amplification in a single tube, the system achieves accurate genotype identification while dramatically improving testing efficiency and reducing both time and cost compared to performing separate PCR tests for each gene

Inventive Principle:
Principle #5Merging (Combining)

3Ease of operation

If conventional PCR primers are used, then the procedure is straightforward, but HBA12 gene amplification fails due to gene conversion

Engineering Contradiction:
Improveprocedure simplicityVSAvoidgene detection reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The primer sets are designed with local quality specificity, where each primer is tailored to recognize and bind to unique sequences within its target gene region. The HBA12-specific primers are designed to target regions that are distinct from HBA1 and HBA2, accounting for the gene conversion characteristics. This localized specificity ensures reliable amplification of HBA12 while maintaining overall procedure simplicity

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides high sensitivity and cost-effectiveness in identifying HBA12 genotypes, minimizing false positives and negatives, and enabling precise diagnosis and treatment of thalassemia and sickle cell anemia.

Implementation Method 1

contacting the sample with at least one set of primers for each of HBA1, HBA2 and HBA12 under conditions suitable for the primers to amplify DNA in the sample by multiplex polymerase chain reaction (PCR)

Methodology Applied
Scientific EffectPolymerase Chain Reaction (PCR):

Data Source

PatentUS12618113B2Genetic test kit for detecting thalassemia
Publication Date: 2026.05.05 IMAM ABDULRAHMAN BIN FAISAL UNIV
  • US12618113B2 patent drawing
  • US12618113B2 patent drawing
  • US12618113B2 patent drawing

AI summary

One aspect of the invention is a method for amplifying alpha globin genes HBA1, HBA2 and HBA12 in a single PCR tube to determine an HBA genotype of a subject. This method employs five primers selected to accurate and sensitively identify the HBA1, HBA2, and HBA12, a gene found at a higher frequency in citizens of Saudi Arabia, by accurately annealing to nucleic acids in a biological sample and simultaneously amplifying sequences encoding the alpha globin genes. This invention includes a procedure and required reagents for the amplification of alpha globin genes in a single PCR tube.